The Europe Sugar Based Excipients Market was calculated to be US$ xx million in 2021, and it is predicted that it will reach US$ xx million by 2026 with an annual expansion rate of xx% between 2021 and 2026.
Excipients are substances that are used in drugs for their correct administration, and they are inactive ingredients that are used to support the active principles of the drug and provide a greater volume and long-term stability of solid formulations. These excipients come in many forms and types, including chewing gum, syrup, and starch. Excipients flavor and coat the medicine in a different color, so the medicine looks different and also provides texture. Excipients are flawless sugars and polymers, complex and even human starches and gelatin. With direct compression becoming the preferred method for making tablets, the demand for compressible sugar-based excipients has increased. Sugar-based excipients are used in glycerol, saccharin sodium, sucrose, sorbitol, etc. They are used primarily in antibiotics and patient syrups. Sugar-based excipients act as fillers, tonicity regulators, diluents, and sweeteners in pharmaceutical formulations. Of all different types, mannitol is considered costly due to its usage in chewable tablets to offer a cooling sensation. And the widespread use of mannitol is creating huge opportunities for the sugar alcohol segment. Sugar-based excipients are the most popular excipients used as part of oral prescription medications. In particular, the test is considered for drugs that are combined with the active ingredient with a bitter taste. Sugar-based excipients have been widely accepted as ingredients in pharmaceutical tableting. They can be used to mask the bitter taste of the active agent and make it more delicious.
The demand for sugar-based excipients is increasing rapidly as the adaptability of the alcohol-based sugar brothers increases in the development of formulation technology such as oral disintegration.
The market for sugar-based excipients in Europe has seen significant growth during the forecast period. Generic drug manufacturers are focusing because most of the drugs that make oral drugs can be taken by special patients for children, so generic drug manufacturers are focusing on the form and testing of the drug to look attractive, children and other patients. Sugar-based excipients are used primarily in the pharmaceutical industry because they are easy to use and can be easily coated into tablets. The increased use of excipients and co-treatment excipients to develop new drug development and improve the bioavailability, dissolution and breakdown of active pharmaceutical ingredients (API), and the growth of the elderly and pediatric population will drive the growth of the market of sugar-based excipients in Europe. In addition, with the expiration of patents for standard drugs in May, the rapidly growing generics segment calls for the use of sugar-based excipients. The top three factors driving the growth of the European sugar-based excipients market include increased use of co-treatment excipients, rapid growth of the generic market due to the completion of many top-selling drugs, and improved disintegration oral (ODT). Most formulations are taken orally and omit the bitter taste of the drug, and sugar-based excipients in the formulation are particularly prominent in pediatric formulations. It also adds bulk to tablets and is used as a thickener in syrup sugar-based excipients.
More of these formulations are driving the growth of the market for sugar-based excipients in Europe. Running mannitol in the form of a wide range of dosages will make the sugar alcohol segment grow larger among other sugar-based excipients. The high adaptability of alcohol-based sugar excipients in new formulation technologies, such as orally disintegrating tablets and others, is another reason why the sugar alcohol segment will experience strong growth in the coming years. According to the type of sugar-based excipients, granulated sugar-based excipients have been widely used in pharmaceutical industry and occupied a large proportion.Sugar-based excipients are in high demand in the pharmaceutical industry for oral drug manufacturing, medical innovation and manufacturing market players and government agencies are investing in research to find more innovative products, and the generic market is in the following important forms. Great demand for sugar-based excipients for the manufacture of pharmaceutical products.
The demand and need for sugar-based excipients in the market is widespread, and some factors, such as the lack of FDA-approved manufacturing sites due to strict regulatory requirements, hinder the growth of the sugar-based excipients market. Stringent regulatory requirements leading to a shortage of FDA-approved products tend to slow market growth to some extent.
Depending on the product, the market is segmented into actual sugar, sugaralcohols, and artificial sweeteners. The actual sugar segment is expected to occupy a large market share due to its high use in oral formulations.
In terms of type, the market is divided into granules, crystals, powders and syrups. Granules segment is expected to occupy significant market share as it is widely used in pharmaceutical industry for different kinds of formulations like tablets, capsules and syrups.
Based on functionality, the market is segmented into toners, diluents, fillers, and flavoring. The fragrance sector is supposed to expand at a significant CAGR, which accounts for the high demand for syrup production in the pharmaceutical industry.
On the basis of formulation, the market is divided into parenteral, oral, and topical formulations. Sugar-based excipients are used in oral medications. It is especially considered for prescription drugs for children.
Geographically the Europe Sugar Based Excipients Market is segmented into UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe. Europe dominates the worldwide market due to increased investment in new drug development, increased production of generic drugs, and favorable initiatives by regional governments. According to the European Federation of Pharmaceutical Industries and Associations, in 2017, Europe invested around $ 344 million in R&D. Europe is supposed to occupy a significant market share during the forecast period due to the growth of the pharmaceutical industry, capacity , the availability of profitable manufacturing and the growth of the regional healthcare sector. The sugar-based excipient market is supposed to post a healthy CAGR during the outlook period. Eastern and Western Europe lead the regions in the market for sugar-based additives due to increased investment in factors such as the development of new drugs and the production of generic drugs, as well as favorable government policies.
Key Players in the Market:
Major Key Players in the Europe Sugar Based Excipients Market are
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org